The prevalence and prognostic impact of mutations promoting chromatin remodelling dysregulation in non-resectable or recurrent/metastatic adenoid cystic carcinoma
Rack, Samuel Feeney, L. Mistry, H. Betts, G. Harrington, K. J. Metcalf, Robert
Rack, Samuel
Feeney, L.
Mistry, H.
Betts, G.
Harrington, K. J.
Metcalf, Robert
Citations
Altmetric:
Abstract
Description
Date
2022
Publisher
Collections
Keywords
Type
Meetings and Proceedings
Citation
Rack S, Feeney L, Mistry H, Betts G, Harrington KJ, Metcalf R. The prevalence and prognostic impact of mutations promoting chromatin remodelling dysregulation in non-resectable or recurrent/metastatic adenoid cystic carcinoma. Journal of Clinical Oncology. 2022 Jun;40(16). PubMed PMID: WOS:000863680301789.